A targeted drug combination delays advanced prostate cancer in men with specific DNA repair gene mutations. A large international study led by researchers at UCL has found that a new combination of drugs may substantially slow the progression of an advanced and potentially fatal form of prostate cancer in men with certain genetic mutations. Published […]